CHMP Recommends Darzalex Combo Therapy for Certain Newly Diagnosed Multiple Myeloma Patients
Expanded use of Darzalex (daratumumab) in combination with standard therapy…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreExpanded use of Darzalex (daratumumab) in combination with standard therapy…
Inserting data from genetically similar patients into a machine-learning…
Urine tests may be better than serum…
Karyopharm Therapeutics is seeking accelerated approval for its…
Older multiple myeloma patients who are unable to receive…
A triple combination treatment — dendritic cell vaccination plus …